{"id":45281,"date":"2022-06-20T20:01:56","date_gmt":"2022-06-20T18:01:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\/"},"modified":"2022-06-20T20:01:56","modified_gmt":"2022-06-20T18:01:56","slug":"wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\/","title":{"rendered":"WTO Patents Decision: One Step Forward, Two Steps Back for Health Equity, says AHF"},"content":{"rendered":"
\n

LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF<\/a>) expressed disappointment today with the decision of the World Trade Organization\u2019s Ministerial Conference, which fell short of substantively addressing intellectual property rights roadblocks to COVID-19 vaccine access in developing countries. What has been heralded by some wealthy countries as a breakthrough compromise may indeed prove to be a smokescreen for lack of political will to address global health disparities after two years of fruitless talks.\n<\/p>\n

\n\u201cWe applaud Director-General Ngozi Okonjo-Iweala\u2019s tireless efforts to reach a workable compromise on the patents \u2013 she kept this vital issue at the top of WTO\u2019s agenda, despite many competing priorities. Regrettably, what the ministers at the WTO finally decided on is a far cry from the original proposal advanced by India and South Africa, which sought to rapidly expand generic production of COVID-19 vaccines,\u201d said AHF President Michael Weinstein. \u201cAside from a few, elaborately convoluted exceptions in the ministerial decision\u2014that few countries will qualify for or risk invoking\u2014the disparity in global health equity will remain fundamentally unchanged and beholden to pharmaceutical patent monopolies.\u201d\n<\/p>\n

\nCountries impacted by the lack of COVID-19 vaccines, diagnostics, and therapeutics will be hard-pressed to apply the provisions of the decision in the real world. For one, the decision failed to address the biggest challenge with producing generic vaccines \u2013 the lack of access to knowhow, such as bespoke proteins, cell cultures, and nanotechnology needed to create them.\n<\/p>\n

\nThese components are trade secrets held by drug companies, without which it is not possible to produce a new generation of highly effective biosimilar vaccines in a reasonable amount of time, even if one has a theoretical blueprint from a patent. The scope of the ministerial decision focused entirely on patents; hence technology transfers were omitted from it.\n<\/p>\n

\nAdditionally, eligible countries may only invoke provisions of the decision for five years, and they only apply to patents on vaccines, even though at this stage in the pandemic, the need for treatment is arguably becoming more important.\n<\/p>\n

\nThe decision does stipulate that in six months, WTO Members will consider expanding the policy to include diagnostics and therapeutics. The eligibility criteria themselves, however, limit the practical usefulness of the decision to developing countries, of which many lack the capacity for domestic vaccine production at scale.\n<\/p>\n

\nSome critics of the decision have argued that it is in fact a step backward from the prevailing status quo surrounding the TRIPS flexibilities because it has introduced a slew of minute parameters and constraints that might set a precedent unfavorable to the spirit of TRIPS \u2013 namely, to give countries the right and legal protections to ignore patents during emergencies in the interest of public health.\n<\/p>\n

\nAfter a drawn-out struggle at the WTO, one thing is clear \u2013 advocacy to prioritize people\u2019s lives over corporate profits is far from over for civil society and concerned citizens around the world.\n<\/p>\n

\nAIDS Healthcare Foundation<\/b> (AHF), the largest global nonprofit AIDS organization, currently provides medical care and\/or services to over 1.6 million clients in 45 countries worldwide in the US, Africa, Latin America\/Caribbean, the Asia\/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org<\/a>, find us on Facebook: www.facebook.com\/aidshealth<\/a> and follow us on Twitter: @aidshealthcare<\/a> and Instagram: @aidshealthcare<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nUS MEDIA CONTACT:
\n
Ged Kenslea<\/b>, <\/b>Senior Director, Communications, AHF
\n
+1.323.308.1833 work +1.323.791.5526 mobile
\n
gedk@aidshealth.org<\/a>\n<\/p>\n

\nDenys Nazarov, <\/b>Director of Global Policy & Communications, AHF
\n
+1 323.308.1829
\n
denys.nazarov@ahf.org<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) expressed disappointment today with the decision of the World Trade Organization\u2019s Ministerial Conference, which fell short of substantively addressing intellectual property rights roadblocks to COVID-19 vaccine access in developing countries. What has been heralded by some wealthy countries as a breakthrough compromise may indeed prove to be a smokescreen … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45281","6":"format-standard","7":"category-industry"},"yoast_head":"\nWTO Patents Decision: One Step Forward, Two Steps Back for Health Equity, says AHF - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WTO Patents Decision: One Step Forward, Two Steps Back for Health Equity, says AHF - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) expressed disappointment today with the decision of the World Trade Organization\u2019s Ministerial Conference, which fell short of substantively addressing intellectual property rights roadblocks to COVID-19 vaccine access in developing countries. What has been heralded by some wealthy countries as a breakthrough compromise may indeed prove to be a smokescreen ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-20T18:01:56+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"WTO Patents Decision: One Step Forward, Two Steps Back for Health Equity, says AHF\",\"datePublished\":\"2022-06-20T18:01:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\\\/\"},\"wordCount\":588,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\\\/\",\"name\":\"WTO Patents Decision: One Step Forward, Two Steps Back for Health Equity, says AHF - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-06-20T18:01:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"WTO Patents Decision: One Step Forward, Two Steps Back for Health Equity, says AHF\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WTO Patents Decision: One Step Forward, Two Steps Back for Health Equity, says AHF - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\/","og_locale":"en_US","og_type":"article","og_title":"WTO Patents Decision: One Step Forward, Two Steps Back for Health Equity, says AHF - Pharma Trend","og_description":"LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) expressed disappointment today with the decision of the World Trade Organization\u2019s Ministerial Conference, which fell short of substantively addressing intellectual property rights roadblocks to COVID-19 vaccine access in developing countries. What has been heralded by some wealthy countries as a breakthrough compromise may indeed prove to be a smokescreen ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-20T18:01:56+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"WTO Patents Decision: One Step Forward, Two Steps Back for Health Equity, says AHF","datePublished":"2022-06-20T18:01:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\/"},"wordCount":588,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\/","url":"https:\/\/pharma-trend.com\/en\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\/","name":"WTO Patents Decision: One Step Forward, Two Steps Back for Health Equity, says AHF - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-06-20T18:01:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/wto-patents-decision-one-step-forward-two-steps-back-for-health-equity-says-ahf\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"WTO Patents Decision: One Step Forward, Two Steps Back for Health Equity, says AHF"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45281","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45281"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45281\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}